Palisade Bio, Inc.
PALI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2 | $61 | $69 | $182 |
| - Cash | $10 | $12 | $12 | $10 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$7 | $48 | $57 | $171 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | 100% | – | – |
| EBITDA | -$14 | -$12 | -$14 | -$24 |
| % Margin | – | -4,912.4% | – | – |
| Net Income | -$14 | -$12 | -$14 | -$27 |
| % Margin | – | -4,920% | – | – |
| EPS Diluted | -10.19 | -27.01 | -16.53 | -2,546.1 |
| % Growth | 62.3% | -63.4% | 99.4% | – |
| Operating Cash Flow | -$12 | -$11 | -$13 | -$15 |
| Capital Expenditures | $0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$12 | -$11 | -$13 | -$15 |